ArticleBMJ open2026

Clinical safety and preliminary efficacy of allogeneic human induced pluripotent stem cell-derived exosomes in patients with acute ischaemic stroke: protocol of a phase I/II clinical trial in China.

Gaoting Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.